Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Guillain-Barré Syndrome is a rare neurological disorder where the body’s immune system—which normally protects it from ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

Over-exposure to an allergen also raises the risk of allergies, says David Cor ry, MD, professor of medicine in the section ...

The Great British Bake Off winner, 40, is based in Leeds and has three children - two sons, Musa and Dawud, and a younger ...

Leap Therapeutics, Inc.'s DKN-01 trial results show mixed outcomes in cancer treatment, prompting potential future funding ...

Additional funding from new investor Korys, joining existing syndicate members Novo Holdings and Bioqube Ventures, brings total seed financing to €21.5mFunds will be used to further develop ...

In the midst of pandemic upheaval, researchers have gained fundamental insights about how the body fends off infections.

A study to determine the extent of such blood-borne infections in Ireland also found that the prevalence of both viruses was ...

The next phase of pre-exposure prophylaxis against SARS-CoV-2 currently rests on the shoulders of a single monoclonal ...